ABOS logo

Acumen Pharmaceuticals (ABOS) Net Income

Annual Net Income

-$52.37 M
-$9.52 M-22.20%

31 December 2023

ABOS Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$29.77 M
-$9.23 M-44.93%

30 September 2024

ABOS Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$81.67 M
-$16.81 M-25.91%

30 September 2024

ABOS TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABOS Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-22.2%-129.7%-67.6%
3 y3 years-615.0%-662.8%+12.2%
5 y5 years---

ABOS Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-615.0%+47.9%-662.8%at low-159.0%+18.8%
5 y5 years-615.0%+47.9%-3842.4%+51.5%-3893.7%+18.8%
alltimeall time-615.0%+47.9%-3842.4%+51.5%-3893.7%+18.8%

Acumen Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$29.77 M(+44.9%)
-$81.67 M(+25.9%)
June 2024
-
-$20.54 M(+38.1%)
-$64.86 M(+16.0%)
Mar 2024
-
-$14.87 M(-9.8%)
-$55.94 M(+6.8%)
Dec 2023
-$52.37 M(+22.2%)
-$16.50 M(+27.3%)
-$52.37 M(+7.4%)
Sept 2023
-
-$12.96 M(+11.6%)
-$48.74 M(+4.8%)
June 2023
-
-$11.61 M(+2.7%)
-$46.49 M(+3.2%)
Mar 2023
-
-$11.31 M(-12.1%)
-$45.03 M(+5.1%)
Dec 2022
-$42.86 M
-$12.87 M(+20.1%)
-$42.86 M(+11.8%)
Sept 2022
-
-$10.71 M(+5.5%)
-$38.34 M(+21.6%)
June 2022
-
-$10.15 M(+11.2%)
-$31.53 M(-61.9%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$9.13 M(+9.3%)
-$82.74 M(-17.8%)
Dec 2021
-$100.61 M(+1273.5%)
-$8.35 M(+114.0%)
-$100.61 M(+8.2%)
Sept 2021
-
-$3.90 M(-93.6%)
-$93.01 M(+1.5%)
June 2021
-
-$61.36 M(+127.3%)
-$91.60 M(+183.8%)
Mar 2021
-
-$27.00 M(+3475.8%)
-$32.28 M(+340.6%)
Dec 2020
-$7.33 M(-7.4%)
-
-
Dec 2020
-
-$755.00 K(-69.7%)
-$7.33 M(+11.5%)
Sept 2020
-
-$2.49 M(+22.4%)
-$6.57 M(+61.0%)
June 2020
-
-$2.04 M(-0.5%)
-$4.08 M(+99.5%)
Mar 2020
-
-$2.04 M
-$2.04 M
Dec 2019
-$7.91 M
-
-

FAQ

  • What is Acumen Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Acumen Pharmaceuticals?
  • What is Acumen Pharmaceuticals annual net income year-on-year change?
  • What is Acumen Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Acumen Pharmaceuticals?
  • What is Acumen Pharmaceuticals quarterly net income year-on-year change?
  • What is Acumen Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Acumen Pharmaceuticals?
  • What is Acumen Pharmaceuticals TTM net income year-on-year change?

What is Acumen Pharmaceuticals annual net profit?

The current annual net income of ABOS is -$52.37 M

What is the all time high annual net income for Acumen Pharmaceuticals?

Acumen Pharmaceuticals all-time high annual net profit is -$7.33 M

What is Acumen Pharmaceuticals annual net income year-on-year change?

Over the past year, ABOS annual net profit has changed by -$9.52 M (-22.20%)

What is Acumen Pharmaceuticals quarterly net profit?

The current quarterly net income of ABOS is -$29.77 M

What is the all time high quarterly net income for Acumen Pharmaceuticals?

Acumen Pharmaceuticals all-time high quarterly net profit is -$755.00 K

What is Acumen Pharmaceuticals quarterly net income year-on-year change?

Over the past year, ABOS quarterly net profit has changed by -$16.81 M (-129.72%)

What is Acumen Pharmaceuticals TTM net profit?

The current TTM net income of ABOS is -$81.67 M

What is the all time high TTM net income for Acumen Pharmaceuticals?

Acumen Pharmaceuticals all-time high TTM net profit is -$2.04 M

What is Acumen Pharmaceuticals TTM net income year-on-year change?

Over the past year, ABOS TTM net profit has changed by -$32.93 M (-67.57%)